Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Umoke Ifeanyi is a consultant general surgeon at Kubwa general hospital in Abuja Nigeria. He is a fellow of the West African College of Surgeons, FWACS. His residency training was in University of Abuja Teaching hospital, UATH, Gwagwalada Abuja Nigeria. He was a three-time president of the association of resident doctors of Nigeria UATH and Ebonyi State University Teaching Hospital, EBSUTH, Abakaliki, Nigeria chapters. He is a member of the American Society of Clinical Oncology, ASCO, and lead investigator in UATH of the Globalsurg3 collaborative study on the quality and outcome of surgeries for breast, gastric and colon cancers. His research interest is breast cancer especially mechanisms for metastasis.
Background Breast cancer is a major health burden globally. Now ranked the number one cancer in females, and the leading cause of cancer deaths in females in our environment, outcome indices have remained poor in developing countries. Aim The aim of this study was to ascertain the major challenges to good management outcome of breast cancer patients in our centre. Patients and methods The case notes of all histologically confirmed cases of breast cancer presenting to our centre from January 2016 to December 2017 were reviewed. Information on the variables of interest were extracted using a proforma. Results Fifty-five (55) patients’ case notes were reviewed. All were females. 30.9% of the patients had early disease vs 67.3% with advanced disease. 76.4% had invasive ductal carcinoma. More lesions occurred on the left and the upper outer quadrants.46% of the 37 patients with advanced disease who required chemotherapy completed the prescribed six courses. None of the patients who required radiotherapy received it. Only 1.8% of those who required hormonal therapy were still taking them at two years follow-up. 3.6%, 11%, and 0% used alcohol, oral contraceptives and tobacco respectively. 81.8% had been lost to follow-up at two years while 14.5% had died while on admission. Conclusion This study identified late presentation with advanced disease; poor compliance and adherence to treatment strategies, and poor access to adjuvant therapy as the major challenges to good outcome for this disease.